PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 13 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,375,000 | -34.5% | 15,000,000 | 0.0% | 0.50% | -38.7% |
| Q2 2018 | $5,149,000 | -14.6% | 15,000,000 | 0.0% | 0.81% | -13.6% |
| Q1 2018 | $6,027,000 | +0.6% | 15,000,000 | 0.0% | 0.94% | -4.1% |
| Q4 2017 | $5,989,000 | +0.1% | 15,000,000 | 0.0% | 0.98% | +10.6% |
| Q3 2017 | $5,983,000 | +49.6% | 15,000,000 | 0.0% | 0.88% | +82.1% |
| Q2 2017 | $3,999,000 | -1.2% | 15,000,000 | -3.2% | 0.49% | -0.8% |
| Q1 2017 | $4,049,000 | +13.6% | 15,500,000 | 0.0% | 0.49% | +23.7% |
| Q4 2016 | $3,565,000 | -17.9% | 15,500,000 | 0.0% | 0.40% | +1.8% |
| Q3 2016 | $4,340,000 | +21.7% | 15,500,000 | 0.0% | 0.39% | +12.1% |
| Q2 2016 | $3,565,000 | – | 15,500,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 9,000,000 | $2,542,000 | 1.20% |
| ARMISTICE CAPITAL, LLC | 22,760,000 | $7,053,000 | 0.90% |
| Broadfin Capital, LLC | 15,000,000 | $3,999,000 | 0.49% |
| Avoro Capital Advisors LLC | 6,000,000 | $1,859,000 | 0.24% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 51,775,000 | $14,367,000 | 0.21% |
| Aisling Capital LLC | 2,500,000 | $775,000 | 0.13% |
| Bruce & Co., Inc. | 2,000,000 | $500,000 | 0.11% |
| BARINGS LLC | 7,500,000 | $2,119,000 | 0.06% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 2,000,000 | $621,000 | 0.06% |
| ZAZOVE ASSOCIATES LLC | 2,000,000 | $550,000 | 0.03% |